Osteoporosis Health Center
This article is from the WebMD News Archive
Drinking Tea May Slow Bone Loss
Oct. 8, 2007 -- Drinking tea may be good for your bones.
A new study shows elderly women who drank tea had higher bone density in their hips and less bone loss than women who didn't drink tea.
Researchers say the results confirm previous studies that have suggested drinking tea may protect against bone loss and osteoporosis.
In the study, Australian researchers surveyed 275 women between the ages of 70 and 85 who were participating in a larger five-year study of calcium supplements and osteoporosis about how much black and green tea (but not herbal teas) they drank. Bone density measurements of the hip were also taken at the beginning and end of the five-year study.
The results, published in The American Journal of Clinical Nutrition, showed that women who were regular tea drinkers had higher bone density in two sites in the hip compared with non-tea drinkers.
The bone mineral density in tea drinkers was higher than in non-tea drinkers. Tea drinkers also had less loss of bone density over a four-year period compared with non-tea drinkers. These results took into account factors such as smoking history and use of calcium supplements.
The researchers did not find a relationship between the number of cups of tea consumed per day and bone mineral density.
"Other variables, such as dietary calcium and coffee intake, physical activity, and smoking did not appear to be important confounders of the relation between tea and [bone density]," write researcher Amanda Devine, of the University of Western Australia in Perth, Australia, and colleagues. "Thus, overall our data support the concept that tea intake has beneficial effects on bone structure by reducing bone loss."
Researchers say more research is needed to determine how drinking tea affects bone density. Previous studies have suggested that phytochemicals in tea, such as flavonoids, may be responsible for the protective effect against bone loss due to their estrogen-like properties.
(Do you drink tea? What’s your favorite? Talk about it on WebMD's Bone Health and Osteoporosis: Support Group message board.)
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


